Professor, Obstetrics and Gynecology, University of Texas Medical School at Houston
Obstetrics & Gynecology
Dr. Charles F. Levenback, MD
|
|
Give Review
Charles F. Levenback, MD works in the field of Obstetrics & Gynecology. He graduated from Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He over the years received 4 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACOG)". Doctor Charles F. Levenback, MD is a published doctor as well. He has 52 publications published. The latest was: Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Fighting Cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education.
- Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma.
- Targeting those with decreased meaning and peace: a supportive care opportunity.
- Perioperative blood transfusion in gynecologic oncology surgery: Analysis of the National Surgical Quality Improvement Program Database.
- Improved Compliance With Venous Thromboembolism Pharmacologic Prophylaxis for Patients With Gynecologic Malignancies Hospitalized for Nonsurgical Indications Did Not R...
- Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus.
- A case for caution in the pursuit of the sentinel node in women with endometrial Carcinoma.
- Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiat...
- Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer.
- "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with Cervical cancer.
- Is bilateral lymphadenectomy for midline squamous Carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.
- Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.
- Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell Carcinoma of the vulva: a gynecologic oncology group study.
- Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic Cancer.
- Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery.
- Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous Carcinoma of the ovary, peritoneum, or fallopian tube.
- Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian Cancer.
- Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery.
- Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithe...
- Primary malignant melanoma of the vagina.
- Combination of gemcitabine and cisplatin is highly active in women with endometrial Carcinoma: results of a prospective phase 2 trial.
- Lymphadenectomy during endometrial Cancer staging: practice patterns among gynecologic oncologists.
- Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian Cancer in the setting of normal CA-125 levels.
- Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced Ovarian, tubal, or peritone...
- Sentinel node mapping in vulvoVaginal melanoma using SPECT/CT lymphoscintigraphy.
- Sentinel lymph node biopsy in patients with gynecologic Cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.
- Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital Status matter?
- Parametrial involvement in radical hysterectomy specimens for women with early-stage Cervical cancer.
- Predictive value of a proposed subclassification of stages I and II Cervical cancer based on clinical tumor diameter.
- Lymphatic mapping and sentinel lymph node detection in women with Cervical cancer.
- Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell Carcinoma.
- Is lymphatic mapping in uterine Cancer feasible?
- Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and Cervical cancers.
- Lymphatic mapping and sentinel lymph node detection in women with vaginal Cancer.
- How safe is sentinel lymph node biopsy in patients with vulvar Cancer?
- Comparison of treatment tolerance and outcomes in patients with Cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with sta...
- Status of sentinel lymph node biopsy in gynecological cancers.
- Status of sentinel lymph nodes in cervical cancer.
- Lack of effective systemic therapy for recurrent clear cell Carcinoma of the ovary.
- Has the time come for sentinel lymph node biopsy alone in radical hysterectomy patients?
- Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial Cancer.
- Current perspectives on lymphatic mapping in Carcinomas of the uterine corpus and cervix.
- Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal Cancers.
- Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for Cervical cancer.
- Quality of life and sexual functioning in Cervical cancer survivors.
- Imaging in Cervical cancer.
- The role of radiation therapy in preventing regional recurrences of invasive squamous cell Carcinoma of the vulva.
- A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent Uterine malignant mixed müllerian tumors with evaluation of potential molec...
- Sentinel Lymph Node Evaluation in Women with Cervical Cancer.
Schools
MT SINAI SCH OF MED OF NY UNIV
Albert Einstein College Med
Meml Sloan Kettering Cancer
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- EndoCervical Curettage
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- HealthSmart
- Choice Care PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACOG)
Education
-
Albert Einstein College of Medicine at Jacobi Medical Center -
Albert Einstein - Montefiore Medical Center -
Icahn School of Medicine at Mount Sinai
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1720183049 | |
| NPPES Provider LastName | LEVENBACK | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 156.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 23.0 | |
| Percent Opioid Claims | 14.74 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720183049 |
| Last Name Of The Provider | LEVENBACK |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Robert C. Maier, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard D. Drake, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel W. Law II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Luis E. Castillo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas W. Burke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lisa M. Hollier, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joanie Y. Hare, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aparna A. Kamat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anil K. Sood, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Liz Y. Han, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele Follen, MD
This Doctor is OpenDoctor Recommended.
|